Integra LifeSciences (IART) Reports Prelim. Q4 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/17/2026
- Wall St ends lower for the day and week as chip selloff broadens
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Why the Fed may still need to hike rates
- Assassin's Creed Black Flag Resynced sells 3M copies in a week
- Magnitude 7.4 earthquake strikes coast of Chiapas, Mexico; Tsunami waves are possible
- Magnitude 7.4 earthquake strikes Puerto Madero, Mexico, USGS says
- Nike out of World Cup contention as Adidas-outfitted teams head to final
- Personalis (PSNL) explores potential sale after interest from Merck and others - source
Integra LifeSciences Announces Preliminary Fourth Quarter 2017 Financial Results
January 8, 2018 6:30 AM ESTPreliminary Fourth Quarter Highlights:
Fourth quarter 2017 reported revenue is expected to be approximately $365 million, exceeding the high-end of the companys previous implied guidance range of $345 million to $355 million;Organic revenue growth in the fourth quarter is expected to be about 5.5%, above the companys implied guidance of about 4%;The Company is still evaluating the impact of the Tax Cuts and Jobs Act of 2017 on its GAAP financial results;Fourth quarter 2017 adjusted earnings per share, excluding any impact from the Tax Cuts and Jobs Act of 2017, is expected to exceed the... More